Literature DB >> 18939940

No association of the rs9722 C >T in the S100B gene and susceptibility to major depression in a Chinese population.

Kun Yang1, Yi Qiu Hu, Guang Rong Xie, Fu Qiang Mao, Lin Yan Su.   

Abstract

OBJECTIVE: Astroglial-derived protein S100B is known to play important roles in axonal growth, neural plasticity, and energy regulation. Disturbance of these neurodevelopmental processes is proposed as one of the etiologies for mood disorder, and genetic polymorphisms of S100B have a possibility to be in susceptibility to major depressive disorder (MDD).
METHOD: We first investigated the association of the rs9722 C > T polymorphism of the S100B gene and susceptibility to MDD by comparing 152 major depressive patients with 150 healthy individuals in a Chinese population.
RESULTS: The genotype frequencies of the S100B rs9722 C > T polymorphism were 30% (C/C), 56% (C/T), and 14% (T/T) in depressed patients, 32% (C/C), 53% (C/T), and 15% (T/T) in healthy volunteers, respectively. The allele frequencies of the S100B rs9722 C > T polymorphism were 58% (C allele) and 42% (T allele) in depressed patients, and 59% (C allele) and 41% (T allele) in healthy volunteers, respectively.
CONCLUSION: There were no significant differences in the genotype distribution and allele frequencies between major depressive patients and healthy individuals. S100B rs9722 C > T polymorphism appears not to be an important factor in susceptibility to MDD in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939940     DOI: 10.1089/gte.2008.0023

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  3 in total

1.  Mood disorders are glial disorders: evidence from in vivo studies.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Julia Sacher; Johann Steiner; Ingolf E Blasig; Karsten Mueller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-05-27

Review 2.  Serum S100B represents a new biomarker for mood disorders.

Authors:  Matthias L Schroeter; Julia Sacher; Johann Steiner; Peter Schoenknecht; Karsten Mueller
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

3.  Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders.

Authors:  Aleksandra Rajewska-Rager; Monika Dmitrzak-Weglarz; Pawel Kapelski; Natalia Lepczynska; Joanna Pawlak; Joanna Twarowska-Hauser; Maria Skibinska
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.